Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway

Context Shenmai Injection (SMI) is usually used to treat atherosclerotic coronary heart disease and viral myocarditis in China. However, the effect of SMI on multidrug resistance has not been reported. Objective To investigate the reversal effect of SMI in adriamycin (ADR) resistant breast cancer ce...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lin Yang, Chengda Zhang, Jiaoting Chen, Sheng Zhang, Guixuan Pan, Yanfei Xin, Lin Lin, Zhenqiang You
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2020-01-01
coleção:	Pharmaceutical Biology
Assuntos:	p-glycoprotein apoptosis rhodamine 123
Acesso em linha:	http://dx.doi.org/10.1080/13880209.2020.1742167
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!